scholarly article | Q13442814 |
P356 | DOI | 10.1111/PEDI.12473 |
P698 | PubMed publication ID | 28052534 |
P2093 | author name string | Brigid Gregg | |
Inas Thomas | |||
P2860 | cites work | Metformin: An Update | Q22241145 |
Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes | Q22241283 | ||
Incidence of lactic acidosis in metformin users | Q22241284 | ||
Metformin Treatment to Prevent Early Puberty in Girls with Precocious Pubarche | Q22241661 | ||
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin | Q22250892 | ||
Repurposing metformin: an old drug with new tricks in its binding pockets | Q22250976 | ||
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase | Q22251079 | ||
Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP | Q22251081 | ||
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study | Q24633604 | ||
Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC. | Q39340562 | ||
Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice | Q39640373 | ||
Synergistic Benefit of Statin and Metformin in Gastrointestinal Malignancies | Q40950693 | ||
Activating Endogenous Neural Precursor Cells Using Metformin Leads to Neural Repair and Functional Recovery in a Model of Childhood Brain Injury | Q42041465 | ||
Effect of Metformin on mortality in patients with heart failure and type 2 diabetes mellitus | Q42883064 | ||
Pubertal metformin therapy to reduce total, visceral, and hepatic adiposity | Q43272937 | ||
Metformin treatment for four years to reduce total and visceral fat in low birth weight girls with precocious pubarche. | Q46719157 | ||
Metformin treatment to reduce central adiposity after prenatal growth restraint: a placebo-controlled pilot study in prepubertal children. | Q50458133 | ||
Effect of metformin treatment on insulin action in diabetic rats: in vivo and in vitro correlations. | Q51616426 | ||
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes | Q24642503 | ||
Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age. | Q30407478 | ||
Clinical review: Drugs commonly associated with weight change: a systematic review and meta-analysis | Q33570239 | ||
A risk-benefit assessment of metformin in type 2 diabetes mellitus | Q33678321 | ||
Potential biomarker of metformin action | Q33686430 | ||
Metformin pharmacogenomics: current status and future directions | Q33959731 | ||
An update on the pharmacogenomics of metformin: progress, problems and potential | Q34003050 | ||
Effects of low dose metformin in adolescents with type I diabetes mellitus: a randomized, double-blinded placebo-controlled study | Q34288242 | ||
Oral antihyperglycemic therapy for type 2 diabetes: scientific review | Q34492673 | ||
Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. | Q34506457 | ||
Short- and long-term outcomes of metformin compared with insulin alone in pregnancy: a systematic review and meta-analysis | Q34525288 | ||
Metformin--mode of action and clinical implications for diabetes and cancer | Q34658712 | ||
Traditional plant medicines as treatments for diabetes | Q34675107 | ||
Metabolic effects of metformin in non-insulin-dependent diabetes mellitus | Q34720764 | ||
Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial | Q35031127 | ||
Metformin use and lung cancer risk in patients with diabetes. | Q35046673 | ||
Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota | Q35860108 | ||
Therapeutic Challenges in Diabetes Prevention: We Have Not Found the "Exercise Pill" | Q35880380 | ||
Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study | Q36217890 | ||
Lipid and inflammatory cardiovascular risk worsens over 3 years in youth with type 2 diabetes: the TODAY clinical trial | Q36868110 | ||
Effects of Metformin and Exercise Training, Alone or in Combination, on Cardiac Function in Individuals with Insulin Resistance | Q36999950 | ||
Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials | Q37059366 | ||
Treatment with L-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial | Q37150891 | ||
Metformin: prevention and treatment of antipsychotic-induced weight gain | Q37378262 | ||
An energetic tale of AMPK-independent effects of metformin. | Q37767575 | ||
Efficacy and safety of metformin for treatment of overweight and obesity in adolescents: an updated systematic review and meta-analysis. | Q38056388 | ||
Metformin: from mechanisms of action to therapies | Q38279824 | ||
Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial | Q38399028 | ||
Evaluating the Effects of Metformin Use on Height in Children and Adolescents: A Meta-analysis of Randomized Clinical Trials | Q38594496 | ||
Insulin resistance, role of metformin and other non-insulin therapies in pediatric type 1 diabetes | Q38642435 | ||
Reasons and outcomes of conversion of laparoscopic sleeve gastrectomy to Roux-en-Y gastric bypass for nonresponders | Q38708649 | ||
Adjunctive metformin for antipsychotic-induced hyperprolactinemia: A systematic review | Q38715241 | ||
Involvement of glucagon-like peptide-1 in the glucose-lowering effect of metformin. | Q38855893 | ||
Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial | Q38996447 | ||
P433 | issue | 1 | |
P921 | main subject | metformin | Q19484 |
P304 | page(s) | 10-16 | |
P577 | publication date | 2017-02-01 | |
P1433 | published in | Pediatric Diabetes | Q7159203 |
P1476 | title | Metformin; a review of its history and future: from lilac to longevity | |
P478 | volume | 18 |
Q48302673 | A Review of Insulin Resistance in Type 1 Diabetes: Is There a Place for Adjunctive Metformin? |
Q47240106 | A reappraisal on metformin |
Q64254281 | Association of preadmission metformin use and mortality in patients with sepsis and diabetes mellitus: a systematic review and meta-analysis of cohort studies |
Q60698427 | Blood Biochemistry Analysis to Detect Smoking Status and Quantify Accelerated Aging in Smokers |
Q49193708 | Comparative Study on Adding Pioglitazone or Sitagliptin to Patients with Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin |
Q93364919 | Diabetes pharmacotherapy and effects on the musculoskeletal system |
Q64114703 | Distinct Fractions of an Extract Contain Compounds With Novel Adipogenic Bioactivity |
Q93079853 | Flavonoids and Their Anti-Diabetic Effects: Cellular Mechanisms and Effects to Improve Blood Sugar Levels |
Q51733866 | Groundsel Bush (Baccharis halimifolia) Extract Promotes Adipocyte Differentiation In Vitro and Increases Adiponectin Expression in Mature Adipocytes. |
Q62495171 | Machine Learning on Human Muscle Transcriptomic Data for Biomarker Discovery and Tissue-Specific Drug Target Identification |
Q52668163 | Metformin and berberine, two versatile drugs in treatment of common metabolic diseases. |
Q50050510 | Metformin for Rapidly Maturing Girls with Central Adiposity: Less Liver Fat and Slower Bone Maturation |
Q39376655 | Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity |
Q38692444 | Modified Metformin as a More Potent Anticancer Drug: Mitochondrial Inhibition, Redox Signaling, Antiproliferative Effects and Future EPR Studies. |
Q50015016 | Population specific biomarkers of human aging: a big data study using South Korean, Canadian and Eastern European patient populations. |
Q44871485 | Structural constraints and importance of caffeic acid moiety for anti-hyperglycemic effects of caffeoylquinic acids from chicory |
Q94528642 | Translational Geroscience: From invertebrate models to companion animal and human interventions |
Search more.